Literature DB >> 26239515

A NSQIP Review of Major Morbidity and Mortality of Synchronous Liver Resection for Colorectal Metastasis Stratified by Extent of Liver Resection and Type of Colorectal Resection.

Christopher R Shubert1,2, Elizabeth B Habermann2, John R Bergquist1,2, Cornelius A Thiels1,2, Kristine M Thomsen2, Walter K Kremers2, Michael L Kendrick1, Robert R Cima2,3, David M Nagorney4.   

Abstract

INTRODUCTION: Safety of synchronous hepatectomy and colorectal resection (CRR) for metastatic colorectal cancer remains controversial. We hypothesized that both the extent of hepatectomy and CRR influences postoperative outcomes.
METHODS: Prospective 2005-2013 ACS-NSQIP data were retrospectively reviewed for mortality and major morbidity (MM) after (1) isolated hepatectomy, (2) isolated CRR, and (3) synchronous resection for colorectal cancer. Hepatectomy and CRR risk categories were created based on mortality and MM of respective isolated resections. The synchronous cohort was then stratified based on risk categories. Cumulative asynchronous mortality and MM were estimated compared to that observed in the synchronous cohort via unadjusted relative risk and risk difference.
RESULTS: There were 43,408 patients identified. Among isolated hepatectomy patients (N = 6,661), trisectionectomy and right hepatectomy experienced the greatest mortality and were defined as "major" hepatectomy. Among isolated CRR patients (N = 35,825), diverted left colectomy, abdominoperineal resection, total abdominal colectomy, and total abdominal proctocolectomy experienced the greatest MM and were defined as "high risk" CRR. Synchronous patients (N = 922) were stratified by hepatectomy and CRR risk categories; mortality and MM varied from 0.9 to 5.0 % and 25.5 to 55.0 %, respectively. Mortality and MM were greatest for patients undergoing "high risk" CRR and "major" hepatectomy and lowest for synchronous CRR and "minor" hepatectomy. As both CRR and hepatectomy risk categories increased, there was a significant trend in increasing mortality and MM in synchronous patients. Additionally, comparison of the synchronous resections versus the estimated cumulative asynchronous outcomes showed that (1) mortality was significantly less after synchronous minor hepatectomy and either low or high risk CRR, and (2) neither mortality nor major morbidity differed significantly after major hepatectomy with either high or low risk CRR.
CONCLUSION: Major morbidity after synchronous hepatic and colorectal resections vary incrementally and are related to both the risk of hepatectomy and CRR. Stratification of outcomes by the hepatectomy and CRR components may reflect a more accurate description of risks. Comparison of synchronous and combined outcomes of individual operations supports a potential benefit for synchronous resections with minor hepatectomy.

Entities:  

Keywords:  Colorectal metastasis; Extent of colorectal resection; Extent of liver resection; Risk stratification; Safety of synchronous resection; Synchronous liver resection

Mesh:

Year:  2015        PMID: 26239515     DOI: 10.1007/s11605-015-2895-z

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  35 in total

1.  Surgical management of patients with synchronous colorectal liver metastasis: a multicenter international analysis.

Authors:  Skye C Mayo; Carlo Pulitano; Hugo Marques; Jorge Lamelas; Christopher L Wolfgang; Wassila de Saussure; Michael A Choti; Isabelle Gindrat; Luca Aldrighetti; Eduardo Barrosso; Gilles Mentha; Timothy M Pawlik
Journal:  J Am Coll Surg       Date:  2013-02-21       Impact factor: 6.113

2.  Colorectal cancer statistics, 2014.

Authors:  Rebecca Siegel; Carol Desantis; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2014-03-17       Impact factor: 508.702

3.  Trends in long-term survival following liver resection for hepatic colorectal metastases.

Authors:  Michael A Choti; James V Sitzmann; Marcelo F Tiburi; Wuthi Sumetchotimetha; Ram Rangsin; Richard D Schulick; Keith D Lillemoe; Charles J Yeo; John L Cameron
Journal:  Ann Surg       Date:  2002-06       Impact factor: 12.969

4.  Determinants of short- and long-term outcome in patients undergoing simultaneous resection of colorectal cancer and synchronous colorectal liver metastases.

Authors:  C S D Roxburgh; C H Richards; S J Moug; A K Foulis; D C McMillan; P G Horgan
Journal:  Int J Colorectal Dis       Date:  2011-11-17       Impact factor: 2.571

5.  Colorectal cancer with synchronous resectable liver metastases: monocentric management in a hepatobiliary referral center improves survival outcomes.

Authors:  Luca Viganò; Serena Langella; Alessandro Ferrero; Nadia Russolillo; Elisa Sperti; Lorenzo Capussotti
Journal:  Ann Surg Oncol       Date:  2012-09-26       Impact factor: 5.344

6.  Esophageal atresia and achalasialike esophageal dysmotility.

Authors:  W Cheng; K H Poon; V C H Lui; J L Yong; S Law; K T So; K Tse; P K H Tam
Journal:  J Pediatr Surg       Date:  2004-10       Impact factor: 2.545

7.  Actual 10-year survival after resection of colorectal liver metastases defines cure.

Authors:  James S Tomlinson; William R Jarnagin; Ronald P DeMatteo; Yuman Fong; Peter Kornprat; Mithat Gonen; Nancy Kemeny; Murray F Brennan; Leslie H Blumgart; Michael D'Angelica
Journal:  J Clin Oncol       Date:  2007-10-10       Impact factor: 44.544

8.  Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

Authors:  Leonard B Saltz; Stephen Clarke; Eduardo Díaz-Rubio; Werner Scheithauer; Arie Figer; Ralph Wong; Sheryl Koski; Mikhail Lichinitser; Tsai-Shen Yang; Fernando Rivera; Felix Couture; Florin Sirzén; Jim Cassidy
Journal:  J Clin Oncol       Date:  2008-04-20       Impact factor: 44.544

9.  Simultaneous versus staged resection for synchronous colorectal cancer liver metastases.

Authors:  Robert C G Martin; Vedra Augenstein; Nathan P Reuter; Charles R Scoggins; Kelly M McMasters
Journal:  J Am Coll Surg       Date:  2009-03-26       Impact factor: 6.113

10.  Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer.

Authors:  Brenda K Edwards; Anne-Michelle Noone; Angela B Mariotto; Edgar P Simard; Francis P Boscoe; S Jane Henley; Ahmedin Jemal; Hyunsoon Cho; Robert N Anderson; Betsy A Kohler; Christie R Eheman; Elizabeth M Ward
Journal:  Cancer       Date:  2013-12-16       Impact factor: 6.860

View more
  14 in total

1.  Surgical dilemmas in the management of colorectal liver metastases: The role of timing.

Authors:  Dimitrios Dimitroulis; Gregory Kouraklis
Journal:  World J Gastroenterol       Date:  2016-06-07       Impact factor: 5.742

2.  Predicting morbidity of liver resection.

Authors:  Sudharsan Madhavan; Vishal G Shelat; Su-Lin Soong; Winston W L Woon; Terence Huey; Yiong H Chan; Sameer P Junnarkar
Journal:  Langenbecks Arch Surg       Date:  2018-02-07       Impact factor: 3.445

Review 3.  Outcome quality standards for surgery of colorectal liver metastasis.

Authors:  Manuel Bellver Oliver; Javier Escrig-Sos; Fernando Rotellar Sastre; Ángel Moya-Herráiz; Luis Sabater-Ortí
Journal:  Langenbecks Arch Surg       Date:  2020-06-23       Impact factor: 3.445

4.  Risk Factors for 30-Day Unplanned Readmission and Major Perioperative Complications After Spine Fusion Surgery in Adults: A Review of the National Surgical Quality Improvement Program Database.

Authors:  Alvin W Su; Elizabeth B Habermann; Kristine M Thomsen; Todd A Milbrandt; Ahmad Nassr; A Noelle Larson
Journal:  Spine (Phila Pa 1976)       Date:  2016-10-01       Impact factor: 3.241

Review 5.  Systematic review of partial hepatic resection to treat hepatic metastases in patients with gastric cancer.

Authors:  Di Long; Peng-Cheng Yu; Wei Huang; Yu-Long Luo; Sen Zhang
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

Review 6.  Contemporary surgical management of synchronous colorectal liver metastases.

Authors:  Danielle Collins; Heidi Chua
Journal:  F1000Res       Date:  2017-04-28

7.  Morbidity and mortality of synchronous hepatectomy with cytoreductive surgery/hyperthermic intraperitoneal chemotherapy (CRS/HIPEC).

Authors:  Tyler J Mouw; Jennifer Lu; Meghan Woody-Fowler; John Ashcraft; Joseph Valentino; Peter DiPasco; Joshua Mammen; Mazin Al-Kasspooles
Journal:  J Gastrointest Oncol       Date:  2018-10

8.  Synchronous colorectal liver metastases: a national survey of surgeon opinions on simultaneous resection and multidisciplinary cooperation.

Authors:  Carrie Howard; Thomas W Clements; Janet P Edwards; Anthony R MacLean; W Donald Buie; Elijah Dixon; Sean C Grondin; Anthony Gomes; Michael McColl; Sean P Cleary; Shiva Jayaraman; Renelle Daigle; Chad G Ball
Journal:  Hepatobiliary Surg Nutr       Date:  2018-08       Impact factor: 7.293

9.  Radiofrequency ablation is beneficial in simultaneous treatment of synchronous liver metastases and primary colorectal cancer.

Authors:  Joost Hof; Hanneke J Joosten; Klaas Havenga; Koert P de Jong
Journal:  PLoS One       Date:  2018-03-15       Impact factor: 3.240

10.  Shaping the future of liver surgery: Implementation of experimental insights into liver regeneration.

Authors:  D Pereyra; P Starlinger
Journal:  Eur Surg       Date:  2018-03-06       Impact factor: 0.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.